Linagliptin CAS 668270-12-0 Maʻemaʻe ≥99.0% (HPLC) Kiʻi Hōʻike ʻia o ka Hale Hana

Linagliptin CAS 668270-12-0 Maʻemaʻe ≥99.0% (HPLC) Hale Hana

ʻO ka wehewehe pōkole:

Inoa Kemika: Linagliptin

CAS: 668270-12-0

Maʻemaʻe: ≥99.0% (HPLC)

ʻAno: Keʻokeʻo a i ʻole Keʻokeʻo Crystalline Powder

Linagliptin no ka mālama ʻana i ka maʻi diabetes type II

API, Mea Kiʻekiʻe, Hana Kalepa

E-Mail: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Mea Manufacturer Supply, High Purity, Commercial Production
Inoa Kemika: Linagliptin
CAS: 668270-12-0

Na Waiwai Kemika:

Inoa Kimia	Linagliptin
Nā huaʻōlelo like	BI-1356;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl) -3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H -purine-2,6-dione
Helu CAS	668270-12-0
Helu CAT	RF-API105
Kūlana Kūʻai	Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala	C25H28N8O2
Kaumaha Molecular	472.54
Lae hehee	197.0 a 200.0 ℃
Ka hikiwawe	Hiki ke hoʻoheheʻe ʻia ma DMSO
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Keʻokeʻo a i ʻole ke keʻokeʻo Crystalline pauda
NMR	Kūlike me ka hoʻolālā
Maʻemaʻe / Kaʻina Hanana	≥99.0% (HPLC)
Nalo ma ka maloo	≤0.50%
Koena ma ka Ignition	≤0.10%
Nā Metala Kaumaha	≤10ppm
Na mea pili
Hoʻokahi haumia	≤0.50%
Huina paumaele	≤1.0%
Isomer	≤0.15%
Nā mea hoʻoheheʻe koena
Methanol	≤3000ppm
Isopropanol	≤5000ppm
DMF	≤800ppm
Dichloromethane	≤600ppm
Kūlana hoʻāʻo	Kūlana ʻoihana
Hoʻohana	API

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai.

Pono:

FAQ:

Noi:

ʻO Linagliptin (CAS: 668270-12-0) kahi mea pale DPP-4 i hoʻomohala ʻia e Boehringer Ingelheim no ka mālama ʻana i ka maʻi diabetes type II.ʻElua mau hiʻohiʻona pharmacological e hoʻokaʻawale i ka linagliptin mai nā mea paʻa DPP-4 ʻē aʻe, ʻo ia ka loaʻa ʻana o ka pharmacokinetic profile non-linear a ʻaʻole i hoʻopau mua ʻia e ka ʻōnaehana renal.Ua ʻae ʻia ʻo Linagliptin (hoʻokahi lā i kēlā me kēia lā) e ka US FDA ma 2 Mei 2011 no ka mālama ʻana i ka maʻi diabetes type II.Ke kūʻai ʻia nei e Boehringer Ingelheim a me Lilly.Linagliptin, kūʻai ʻia ma lalo o ka inoa inoa ʻo Tradjenta ma waena o nā mea ʻē aʻe.Hoʻohana pū ʻia me ka hoʻoikaika kino a me ka ʻai.